Expression of the MHC Class II Pathway in Triple-Negative Breast Cancer Tumor Cells is Associated with a Good Prognosis and Infiltrating Lymphocytes

Lignende værker

• TBCRC 002: a phase II, randomized, open-label trial of preoperative letrozole with or without bevacizumab in postmenopausal women with newly diagnosed stage 2/3 hormone receptor-positive and HER2-negative breast cancer
  af: Vaklavas, Christos, et al.
  Udgivet: (2020)
• Recurrent read-through fusion transcripts in breast cancer
  af: Varley, Katherine E., et al.
  Udgivet: (2014)
• IRES inhibition induces terminal differentiation and synchronized death in triple-negative breast cancer and glioblastoma cells
  af: Vaklavas, Christos, et al.
  Udgivet: (2016)
• Expression of the MHC class II in triple-negative breast cancer is associated with tumor-infiltrating lymphocytes and interferon signaling.
  af: In Ah Park, et al.
  Udgivet: (2017-01-01)
• Expression of the MHC class II in triple-negative breast cancer is associated with tumor-infiltrating lymphocytes and interferon signaling
  af: Park, In Ah, et al.
  Udgivet: (2017)